Related Experiment Video

Updated: Apr 18, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

10.1K

Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction

Andrés Orlandini1, Noelia Castellana1, Andrea Pascual1

  • 1ECLA (Estudios Clínicos Latino América), Argentina.

International Journal of Cardiology
|January 25, 2015
PubMed

Insights

Myocardial viability tests are inconclusive for guiding revascularization in left ventricular dysfunction and coronary artery disease (LVD-CAD) patients. While some studies suggest benefits, the evidence remains uncertain for both viable and non-viable myocardium groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Decision-Making

Background:

  • Myocardial viability tests are crucial for revascularization decisions in patients with left ventricular dysfunction and coronary artery disease (LVD-CAD).
  • Assessing myocardial viability aims to optimize treatment strategies for improved patient outcomes.

Purpose of the Study:

  • To systematically review and meta-analyze evidence comparing medical treatment with revascularization in LVD-CAD patients.
  • To determine the impact of myocardial viability on mortality outcomes following revascularization versus medical management.

Main Methods:

  • Systematic review and meta-analysis of 32 non-randomized and 4 randomized studies.
  • Inclusion criteria focused on studies comparing medical treatment with revascularization in LVD-CAD patients with known myocardial viability status.
  • Primary outcome measure was mortality.

Main Results:

  • Non-randomized studies suggested a mortality benefit from revascularization, particularly in patients with viable myocardium.
  • Randomized studies showed no significant mortality benefit of revascularization, irrespective of myocardial viability.
  • No significant difference in outcomes was observed between patients with and without viable myocardium in either study type.

Conclusions:

  • Current data are inconclusive regarding the utility of myocardial viability tests in guiding revascularization decisions for LVD-CAD patients.
  • While some evidence suggests potential benefit in viable myocardium, revascularization's effect remains uncertain, with neutral or adverse outcomes not excluded.
  • Further high-quality research is needed to clarify the role of viability assessment in revascularization strategies.
Abstract

Keywords:
Coronary artery diseaseMyocardial viabilityRevascularization

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.6K
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

20.4K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
807
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
483
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
631
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
472
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806